SOLUBILITY ENHANCEMENT OF SELEXIPAG BY β-CYCLODEXTRIN INCLUSION COMPLEXES
Universal Journal of Pharmaceutical Research · 15.05.2026
DOI: 10.22270/ujpr.v11i2.1529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Universal Journal of Pharmaceutical Research, online erschienen am 15.05.2026. Verfasst von Celse Kwitonda und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Selexipag is an oral, non-prostanoid IP receptor agonist used in treating pulmonary arterial hypertension (PAH). Selexipag has poor aqueous solubility, especially in acidic solution medium. Hence, for the purposes of overcoming solubility limitations associated with selexipag, various techniques such as complexation with appropriate complexing agents have been considered. Cyclodextrins are unique molecules that are cyclic carbohydrates that have been shown to be suitable for the purpose of inclusion complex formation. This is because they form inclusion complexes when combined with insoluble drugs.
Method
The inclusion complex between Selexipag and β-cyclodextrin was prepared using kneading method.
Result
The ability of β-cyclodextrin to increase the solubility of Selexipag has been shown from the results indicating that β-cyclodextrin improves significantly both the solubility and dissolution of selexipag which is a poorly soluble drug. The formation of the inclusion complex was further confirmed using UV-visible spectrophotometry and Fourier transform infrared spectroscopy. In addition, dissolution studies indicated improved dissolution behavior of the complexed drug.
Conclusion
From the results obtained above, β-cyclodextrin appears to be very efficient carrier agent for poorly soluble drugs such as Selexipag which belong to BCS class II. Peer Review History: Received 22 February 2026; Reviewed 9 March 2026; Accepted 17 April; Available online 15 May 2026 Academic Editor: Dr. Ali Abdullah Al-yahawi, Al-Razi university, Department of Pharmacy, Yemen, alyahawipharm@yahoo.com Reviewers: Dr. Mrinal Kanti Bhoumik, Jubilant Cadista Pharmaceutical Inc., mrinal_bhoumik@yahoo.com Dr. Ahmed Tagelsir Mohamed Ali, National University, Sudan, ahmedtagelsir7@hotmail.com
Zitieren
APA
Kwitonda, C., Choki, S., & Diadone, K. G. (2026). SOLUBILITY ENHANCEMENT OF SELEXIPAG BY β-CYCLODEXTRIN INCLUSION COMPLEXES. Universal Journal of Pharmaceutical Research. https://doi.org/10.22270/ujpr.v11i2.1529
Vancouver
Kwitonda C, Choki S, Diadone KG. SOLUBILITY ENHANCEMENT OF SELEXIPAG BY β-CYCLODEXTRIN INCLUSION COMPLEXES. Universal Journal of Pharmaceutical Research. 2026. doi:10.22270/ujpr.v11i2.1529
BibTeX
@article{Kwitonda2026,
author = {Kwitonda, Celse and Choki, Sonam and Diadone, Kule Gift},
title = {SOLUBILITY ENHANCEMENT OF SELEXIPAG BY β-CYCLODEXTRIN INCLUSION COMPLEXES},
journal = {Universal Journal of Pharmaceutical Research},
year = {2026},
doi = {10.22270/ujpr.v11i2.1529}
}
EUVIMED